Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC), 57021 [2019-23201]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 206 / Thursday, October 24, 2019 / Notices
Street NW, Washington, DC 20405,
telephone 202–501–4755. Please cite
OMB Control No. 9000–0096, Patents, in
all correspondence.
Dated: October 17, 2019.
Janet Fry,
Director, Federal Acquisition Policy Division,
Office of Governmentwide Acquisition Policy,
Office of Acquisition Policy, Office of
Governmentwide Policy.
[FR Doc. 2019–23152 Filed 10–23–19; 8:45 am]
BILLING CODE 6820–EP–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC). This
meeting is open to the public limited
only by the space and ports available.
The meeting room accommodates 70
participants and there will be 2,000
ports available. Due to the limited
availability of meeting space, we are
encouraging the pubic to please register
using the link provided: https://
www.surveymonkey.com/r/TPPT2T2.
There will be public comment periods
at the end of each meeting day; from
3:35 p.m.–4:05 p.m. on December 4,
2019 and from 10:40 a.m.–10:55 a.m. on
December 5, 2019.
DATES: The meeting will be held on
December 4, 2019, 9:00 a.m. to 4:40
p.m., EST and December 5, 2019, 9:00
a.m. to 11:30 a.m., EST.
ADDRESSES: Hilton Garden Inn Atlanta—
Buckhead, 3342 Peachtree Road NE,
Atlanta, Georgia 30326 and via
Teleconference: Dial-In Number: 1–800–
475–0522, Participant Code: 7074867.
FOR FURTHER INFORMATION CONTACT:
Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for
Science, NCIPC, CDC, 4770 Buford
Highway NE, Mailstop F–63, Atlanta,
GA 30341, Telephone (770) 488–1430.
Email address: ncipcbsc@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Board will: (1) Conduct,
encourage, cooperate with, and assist
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:34 Oct 23, 2019
Jkt 250001
other appropriate public health
authorities, scientific institutions, and
scientists in the conduct of research,
investigations, experiments,
demonstrations, and studies relating to
the causes, diagnosis, treatment, control,
and prevention of physical and mental
diseases, and other impairments; (2)
assist States and their political
subdivisions in preventing and
suppressing communicable and noncommunicable diseases and other
preventable conditions and in
promoting health and well-being; and
(3) conduct and assist in research and
control activities related to injury. The
Board of Scientific Counselors makes
recommendations regarding policies,
strategies, objectives, and priorities; and
reviews progress toward injury
prevention goals and provides evidence
in injury prevention-related research
and programs. The Board also provides
advice on the appropriate balance of
intramural and extramural research, the
structure, progress and performance of
intramural programs. The Board is
designed to provide guidance on
extramural scientific program matters,
including the: (1) Review of extramural
research concepts for funding
opportunity announcements; (2)
conduct of Secondary Peer Review of
extramural research grants, cooperative
agreements, and contracts applications
received in response to the funding
opportunity announcements as it relates
to the Center’s programmatic balance
and mission; (3) submission of
secondary review recommendations to
the Center Director of applications to be
considered for funding support; (4)
review of research portfolios, and (5)
review of program proposals.
Matters To Be Considered: The agenda
will include Day One: Discussions on
Lung Injury, Overdose Prevention
Research Priorities Update, The Nation’s
Opioid Crisis, Work Implementation for
Workers and Employees (CDC/NIOSH),
and a request for the establishment of an
Opioid Workgroup. Day Two: The
discussions will focus on The
Importance of Accounting for
Contextual Factors when Developing
Strategies to address Health Inequities,
Health Disparities among American
Indian and Alaskan Native Population
and Health Disparities Research
Activities at CDC. Agenda items are
subject to change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
57021
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–23201 Filed 10–23–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3389–PN]
Medicare Program; Application from
Utilization Review Accreditation
Commission for Initial CMS-Approval
of Its Home Infusion Therapy
Accreditation Program
Centers for Medicare and
Medicaid Services (CMS), HHS.
ACTION: Proposed notice.
AGENCY:
This proposed notice
acknowledges the receipt of an
application from Utilization Review
Accreditation Commission for initial
recognition as a national accrediting
organization for suppliers of home
infusion therapy services that wish to
participate in the Medicare program.
Within 60 days of receipt of an
organization’s complete application, the
statute requires CMS to publish a notice
that identifies the national accrediting
body making the request, describes the
nature of the request, and provides at
least a 30-day public comment period.
DATES: To be assured consideration,
comments must be received at one of
the addresses provided below, no later
than 5 p.m. on November 25, 2019.
ADDRESSES: In commenting, please refer
to file code CMS–3389–PN. Because of
staff and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
Comments, including mass comment
submissions, must be submitted in one
of the following three ways (please
choose only one of the ways listed):
1. Electronically. You may submit
electronic comments on this regulation
to https://www.regulations.gov. Follow
the ‘‘Submit a comment’’ instructions.
2. By regular mail. You may mail
written comments to the following
address ONLY: Centers for Medicare &
Medicaid Services, Department of
Health and Human Services, Attention:
CMS–3389–PN, P.O. Box 8016,
Baltimore, MD 21244–8010.
SUMMARY:
E:\FR\FM\24OCN1.SGM
24OCN1
]]>Agencies
[Federal Register Volume 84, Number 206 (Thursday, October 24, 2019)]
[Notices]
[Page 57021]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-23201]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control, (BSC, NCIPC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors,
National Center for Injury Prevention and Control, (BSC, NCIPC). This
meeting is open to the public limited only by the space and ports
available. The meeting room accommodates 70 participants and there will
be 2,000 ports available. Due to the limited availability of meeting
space, we are encouraging the pubic to please register using the link
provided: https://www.surveymonkey.com/r/TPPT2T2.
There will be public comment periods at the end of each meeting
day; from 3:35 p.m.-4:05 p.m. on December 4, 2019 and from 10:40 a.m.-
10:55 a.m. on December 5, 2019.
DATES: The meeting will be held on December 4, 2019, 9:00 a.m. to 4:40
p.m., EST and December 5, 2019, 9:00 a.m. to 11:30 a.m., EST.
ADDRESSES: Hilton Garden Inn Atlanta--Buckhead, 3342 Peachtree Road NE,
Atlanta, Georgia 30326 and via Teleconference: Dial-In Number: 1-800-
475-0522, Participant Code: 7074867.
FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770
Buford Highway NE, Mailstop F-63, Atlanta, GA 30341, Telephone (770)
488-1430. Email address: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Board will: (1) Conduct, encourage, cooperate with,
and assist other appropriate public health authorities, scientific
institutions, and scientists in the conduct of research,
investigations, experiments, demonstrations, and studies relating to
the causes, diagnosis, treatment, control, and prevention of physical
and mental diseases, and other impairments; (2) assist States and their
political subdivisions in preventing and suppressing communicable and
non-communicable diseases and other preventable conditions and in
promoting health and well-being; and (3) conduct and assist in research
and control activities related to injury. The Board of Scientific
Counselors makes recommendations regarding policies, strategies,
objectives, and priorities; and reviews progress toward injury
prevention goals and provides evidence in injury prevention-related
research and programs. The Board also provides advice on the
appropriate balance of intramural and extramural research, the
structure, progress and performance of intramural programs. The Board
is designed to provide guidance on extramural scientific program
matters, including the: (1) Review of extramural research concepts for
funding opportunity announcements; (2) conduct of Secondary Peer Review
of extramural research grants, cooperative agreements, and contracts
applications received in response to the funding opportunity
announcements as it relates to the Center's programmatic balance and
mission; (3) submission of secondary review recommendations to the
Center Director of applications to be considered for funding support;
(4) review of research portfolios, and (5) review of program proposals.
Matters To Be Considered: The agenda will include Day One:
Discussions on Lung Injury, Overdose Prevention Research Priorities
Update, The Nation's Opioid Crisis, Work Implementation for Workers and
Employees (CDC/NIOSH), and a request for the establishment of an Opioid
Workgroup. Day Two: The discussions will focus on The Importance of
Accounting for Contextual Factors when Developing Strategies to address
Health Inequities, Health Disparities among American Indian and Alaskan
Native Population and Health Disparities Research Activities at CDC.
Agenda items are subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-23201 Filed 10-23-19; 8:45 am]
BILLING CODE 4163-18-P
